These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. miR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation. Xue F; Li H; Zhang J; Lu J; Xia Y; Xia Q Genes Immun; 2013 Mar; 14(2):127-31. PubMed ID: 23303246 [TBL] [Abstract][Full Text] [Related]
4. [TCRζ gene expression in TCR gene-modified T cells specific for DLBCL-associated antigen]. Yin QS; Chen SH; Yang LJ; Zha XF; Li B; Li YQ Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Feb; 27(2):150-3. PubMed ID: 21315043 [TBL] [Abstract][Full Text] [Related]
5. A T-cell receptor gamma/CD3 complex found on cloned functional lymphocytes. Borst J; van de Griend RJ; van Oostveen JW; Ang SL; Melief CJ; Seidman JG; Bolhuis RL Nature; 1987 Feb 19-25; 325(6106):683-8. PubMed ID: 3102966 [TBL] [Abstract][Full Text] [Related]
7. The gamma delta T cell receptor. Koning F; Coligan JE Year Immunol; 1989; 4():94-109. PubMed ID: 2538975 [No Abstract] [Full Text] [Related]
8. The structure of the T cell receptor for antigen is correlated with T cell specificity. Fink PJ; Matis LA; Sorger SB; Hedrick SM Year Immunol; 1988; 3():62-79. PubMed ID: 2831681 [No Abstract] [Full Text] [Related]
9. Selection of the T-cell repertoire: receptor-controlled checkpoints in T-cell development. von Boehmer H Adv Immunol; 2004; 84():201-38. PubMed ID: 15246254 [No Abstract] [Full Text] [Related]
10. Dual TCR T cells: gaining entry into the periphery. Gavin MA; Rudensky AY Nat Immunol; 2002 Feb; 3(2):109-10. PubMed ID: 11812982 [No Abstract] [Full Text] [Related]
11. Preclinical development of T cell receptor gene therapy. Bendle GM; Haanen JB; Schumacher TN Curr Opin Immunol; 2009 Apr; 21(2):209-14. PubMed ID: 19321326 [TBL] [Abstract][Full Text] [Related]
12. Natural T cells: cranking up the immune system by prompt cytokine secretion. Joyce S Proc Natl Acad Sci U S A; 2000 Jun; 97(13):6933-5. PubMed ID: 10860950 [No Abstract] [Full Text] [Related]
13. Armed T cells with CAR for cancer immunotherapy. Wei YQ Sci China Life Sci; 2016 Apr; 59(4):331-2. PubMed ID: 27080712 [No Abstract] [Full Text] [Related]
14. The T cell receptor/CD3 complex: a dynamic protein ensemble. Clevers H; Alarcon B; Wileman T; Terhorst C Annu Rev Immunol; 1988; 6():629-62. PubMed ID: 3289580 [No Abstract] [Full Text] [Related]
15. Lack of fair play in the T cell response. Lanzavecchia A Nat Immunol; 2002 Jan; 3(1):9-10. PubMed ID: 11753400 [No Abstract] [Full Text] [Related]
16. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. Eyquem J; Mansilla-Soto J; Giavridis T; van der Stegen SJ; Hamieh M; Cunanan KM; Odak A; Gönen M; Sadelain M Nature; 2017 Mar; 543(7643):113-117. PubMed ID: 28225754 [TBL] [Abstract][Full Text] [Related]
17. Regulation of the T cell receptor genes: the beginnings of the evidence. Bergelson J; Finberg RW Year Immunol; 1988; 3():53-61. PubMed ID: 3327321 [No Abstract] [Full Text] [Related]
18. Viral Engineering of Chimeric Antigen Receptor Expression on Murine and Human T Lymphocytes. Hammill JA; Afsahi A; Bramson JL; Helsen CW Methods Mol Biol; 2016; 1458():137-57. PubMed ID: 27581020 [TBL] [Abstract][Full Text] [Related]
19. If at first you don't succeed. Fink PJ Nat Immunol; 2000 Oct; 1(4):271-2. PubMed ID: 11017092 [No Abstract] [Full Text] [Related]
20. T cell receptor gene diversity and selection. Davis MM Annu Rev Biochem; 1990; 59():475-96. PubMed ID: 2197981 [No Abstract] [Full Text] [Related] [Next] [New Search]